Neurodevelopmental outcomes at five years in children born very preterm (24–31 weeks) exposed to opioids with or without midazolam: results from the French nationwide EPIPAGE-2 cohort study
- DOI
- 10.1016/j.lanepe.2025.101242
- Published
- 2025-05
- Container
- The Lancet Regional Health - Europe
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.lanepe.2025.101242,
title = {Neurodevelopmental outcomes at five years in children born very preterm (24–31 weeks) exposed to opioids with or without midazolam: results from the French nationwide EPIPAGE-2 cohort study},
author = {Elizabeth Walter-Nicolet and Laetitia Marchand-Martin and Andrei S. Morgan and Monique Kaminski and Valérie Benhammou and Pierre-Yves Ancel and Pierre Tourneux and Véronique Pierrat and Xavier Durrmeyer},
year = {2025},
journal = {The Lancet Regional Health - Europe},
doi = {10.1016/j.lanepe.2025.101242},
url = {https://doi.org/10.1016/j.lanepe.2025.101242}
}RIS
TY - JOUR TI - Neurodevelopmental outcomes at five years in children born very preterm (24–31 weeks) exposed to opioids with or without midazolam: results from the French nationwide EPIPAGE-2 cohort study AU - Elizabeth Walter-Nicolet AU - Laetitia Marchand-Martin AU - Andrei S. Morgan AU - Monique Kaminski AU - Valérie Benhammou AU - Pierre-Yves Ancel AU - Pierre Tourneux AU - Véronique Pierrat AU - Xavier Durrmeyer PY - 2025 JO - The Lancet Regional Health - Europe DO - 10.1016/j.lanepe.2025.101242 UR - https://doi.org/10.1016/j.lanepe.2025.101242 ER -
APA
Walter-Nicolet, E., Marchand-Martin, L., Morgan, A. S., Kaminski, M., Benhammou, V., Ancel, P., Tourneux, P., Pierrat, V., & Durrmeyer, X. (2025). Neurodevelopmental outcomes at five years in children born very preterm (24–31 weeks) exposed to opioids with or without midazolam: results from the French nationwide EPIPAGE-2 cohort study. The Lancet Regional Health - Europe. https://doi.org/10.1016/j.lanepe.2025.101242
Source records
- crossref · retrieved 2026-09-26T02:50:49.577Z